Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic haloperidol-amphetamine interactions and mesolimbic dopamine.

M R Lynch1, H G Kuhn, R J Carey

  • 1Veterans Administration Medical Center, Syracuse, N.Y.

Neuropsychobiology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular fitness in late adolescent males and later risk of serious non-affective mental disorders: a prospective, population-based study.

Psychological medicine·2017
Same author

Cardiovascular fitness in early adulthood and future suicidal behaviour in men followed for up to 42 years.

Psychological medicine·2013
Same author

Grafting of neural stem and progenitor cells to the hippocampus of young, irradiated mice causes gliosis and disrupts the granule cell layer.

Cell death & disease·2013
Same author

Behavioural interaction between the NMDA antagonist MK-801 and the dopaminergic antagonist haloperidol: support for a balance model.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Pavlovian conditioning of CNS drug effects: a critical review and new experimental design.

Reviews in the neurosciences·2011
Same author

Apoptosis-inducing factor deficiency decreases the proliferation rate and protects the subventricular zone against ionizing radiation.

Cell death & disease·2011

Chronic low-dose haloperidol did not induce tolerance, suggesting its utility in modeling long-term antipsychotic effects. Mesolimbic dopamine levels correlated with locomotor activity, indicating its role in amphetamine-induced behavior.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Low-dose amphetamine-induced locomotor activity in rats is modulated by the mesolimbic dopaminergic system.
  • Neuroleptic antagonism of this behavior serves as a potential model for studying antipsychotic drug activity.

Purpose of the Study:

  • To investigate the effects of chronic low-dose amphetamine and haloperidol, alone and in combination, on locomotor activity and mesolimbic dopamine.
  • To assess the development of tolerance to haloperidol's behavioral and biochemical effects over 21 days.

Main Methods:

  • Rats received daily treatment with 1.0 mg/kg amphetamine, 0.1 mg/kg haloperidol, or a combination for 21 days.
  • Locomotor activity was measured in an open field on day 21.
  • Mesolimbic dopamine and its metabolites were analyzed biochemically.

Related Experiment Videos

Main Results:

  • Mesolimbic dopamine concentrations positively correlated with locomotor activity, while metabolites were inversely correlated.
  • Combined treatment resulted in saline-like locomotor activity and mesolimbic dopamine levels.
  • Chronic low-dose haloperidol did not induce behavioral or biochemical tolerance.

Conclusions:

  • Mesolimbic dopamine plays a crucial role in mediating amphetamine-induced locomotor activity.
  • Chronic low-dose haloperidol treatment does not lead to tolerance, mirroring the clinical profile of antipsychotics.
  • Animal models using chronic low-dose neuroleptics are valuable for studying long-term antipsychotic treatment effects.